The hypothesis today is that UCP2 would be repressed in the tumor initiation phases to allow the accumulation of ROS, as described above, while on the contrary the protein would be overexpressed in the late phase to maintain the proliferative capacities of the cells in the tumor microenvironment (TME) that are already under stress conditions [120,124]. The gene discussed is UCP2; the disease is neoplasm.